Home › Pouchitis › New York
Pouchitis clinical trials in New York
5 studies for Pouchitis are looking for participants at sites in New York.
Cities in New York
Etrasimod as Prevention of Pouchitis
- Icahn School Of Medicine at Mount Sinai, New York
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 21, 2026 · NCT07486921Fecal Microbiota Transplant for Patients With Chronic Pouchitis
- Icahn School of Medicine at Mount Sinai, New York
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05829109Rifaximin for the Secondary Prevention of Recurrent Pouchitis
- NYU IBD Center, New York
RecruitingPhase 4
Ages 18 to 74 · All sexes · Updated Aug 3, 2026 · NCT06312683Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF)
- NYU Langone Health, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 28, 2026 · NCT05938465Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch
- NYU Langone Health, New York
RecruitingPhase 4
Ages 18 to 80 · All sexes · Updated Jan 30, 2026 · NCT06864403From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.